Clinical-only: Metabolic / Weight Loss (Retatrutide + Cagrilintide)
Retatrutide (LY-343794)
PLACEHOLDER
MODERATE
1mg
Cagrilintide
PLACEHOLDER
MODERATE
1mg
No interactions detected
Each dose includes evidence rationale · doses personalized to your weight
AI risk assessment
Context: No wearable data
PROAI risk assessment is available with Pro.
See plansSupplements
2 items
PLACEHOLDER · Other
Body weight reductionPhase 3 registrational program design (TRIUMPH)
Human phase 2 RCT evidence for weight loss in obesity.
1mg
PLACEHOLDER · Other
Body weight reduction (phase 3 — REDEFINE 1, overweight/obesity without diabetes)Body weight & glycemic control (phase 3 — REDEFINE 2, type 2 diabetes)Weight loss & glycemic control — late-stage trial report (type 2 diabetes)
Clinical trial evidence in obesity programs (often combination development).
1mg
Similar community stacks
Browse all →gutdigestionresearch-only
Groups gut-inflammation oriented peptides (mostly studied in preclinical colitis/inflammation models).
KPV
1mg
BPC-157
1mg
Magnesium (Glycinate)
400mg
New
recoveryskinresearch-only
Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect & component-based.
BPC-157
1mg
TB500 (TB4 / Thymosin Beta-4)
1mg
GHK-Cu
1mg
New
metabolicweight-managementblood-sugar
Metabolic Health & Weight Management
by@athlete
Metformin & intermittent fasting are combined to support metabolic health & weight management. Metformin improves insulin sensitivity & glucose metabolism, while intermittent fasting aids in weight management & metabolic regulation.
Metformin
500mg
Intermittent Fasting
0mg
New
Community Insights
My notes▾
Sign in to keep a private note on Clinical-only: Metabolic / Weight Loss (Retatrutide + Cagrilintide).